医薬品賦形剤の世界市場：2020年～2027年

医薬品賦形剤は、製薬業界の成長、機能性賦形剤の進歩、希少疾患用医薬品の導入、バイオ医薬品の浸透などの要因によって促進されています。多機能賦形剤の出現、医薬品製造の発展途上市場への移行、バイオシミラー業界の急増が、医薬品賦形剤市場の企業に大きな成長の見通しを提供します。

当レポートでは、世界の医薬品賦形剤市場について調査分析し、業界分析、セグメント別の市場分析、競合情勢、主要企業などについて、体系的な情報を提供しています。

目次

第1章 世界の医薬品賦形剤市場の調査手法と調査範囲

第2章 世界の医薬品賦形剤市場：市場定義と市場概要

第3章 世界の医薬品賦形剤市場：エグゼクティブサマリー

第4章 世界の医薬品賦形剤市場：市場力学

• 市場に影響を与える要因
  • 促進要因
  • 抑制要因
  • 影響分析

第5章 世界の医薬品賦形剤市場：業界分析

• ポーターのファイブフォース分析
• サプライチェーン分析
• バリューチェーン分析
• PEST分析
• 価格分析
• 規制分析
• 償還分析
• アンメットニーズ
• 特許動向

第6章 世界の医薬品賦形剤市場：COVID-19の分析

• 市場に対するCOVID-19の分析
• COVID-19における価格動向
• 需給スペクトル
• パンデミック時の市場に関連する政府のイニシアチブ
• メーカーの戦略的イニシアチブ
• 結論

第7章 世界の医薬品賦形剤市場：製品別

• イントロダクション
• 製品セグメント別の市場規模分析・前年比成長率分析
• 製品セグメント別の市場魅力指数
  • 有機
  • 無機
  • その他

第8章 世界の医薬品賦形剤市場：機能別

• イントロダクション
• 機能セグメント別の市場規模分析・前年比成長率分析
• 機能セグメント別の市場魅力指数
  • 充填剤
  • 希釈剤
  • コーティング剤
  • 崩壊剤
  • その他

第9章 世界の医薬品賦形剤市場：剤形別

• イントロダクション
• 剤形セグメント別の市場規模分析・前年比成長率分析
• 剤形セグメント別の市場魅力指数
  • 経口
  • 非経口
  • 局所
  • その他

第10章 世界の医薬品賦形剤市場：地域別

• イントロダクション
• 地域別の市場規模分析・前年比成長率分析
• 地域別の市場魅力指数
• 北米
• 欧州
• 南米
• アジア太平洋地域
• 中東・アフリカ

第11章 世界の医薬品賦形剤市場：競合情勢

• 競合シナリオ
• 市場ポジショニング/シェア分析
• M&A分析

第12章 世界の医薬品賦形剤市場：企業プロファイル

• DuPont de Nemours Inc
• Roquette Feres.
• Ashland Global Holdings Inc..
• BASF SE.
• Evonik Industries AG.
• Associated British Foods plc
• Archer Daniels Midland Company
• Lubrizol Corporation.
• Croda International
• Innophos Holdings、など

第13章 世界の医薬品賦形剤市場：重要考察

第14章 世界の医薬品賦形剤市場：DataM Intelligence

Global Pharmaceutical Excipients Market is segmented By Product (Organic, Inorganic, Other), By Functionality (Fillers, Diluents, Coatings, Disintegrants, Others), By Formulation (Oral, Parenteral, Topical, Others), and By Region (North America, Latin America, Europe, Asia Pacific, Middle East, and Africa) - Share, Size, Outlook, and Opportunity Analysis, 2020-2027

Market Overview

The Global Pharmaceutical Excipients Market is expected to grow at a CAGR of 5.5% during the forecasting period (2020-2027).

Pharmaceutical excipients are harmless compounds that are used in the production process or are used in the dosage form of a pharmaceutical product but are not the pharmacologically active component. Excipients are often used in drug formulation to provide long-term stabilization, bulk up stable formulations, and aid absorption. They often improve the product's overall protection or reliability during storage or use.

Source: DataM Intelligence Analysis (2019)

Market Dynamics

Pharmaceutical excipients are being driven by factors such as the growing pharmaceutical industry, advances in functional excipients, the introduction of orphan drugs, and the penetration of biopharmaceuticals. The advent of multifunctional excipients, the transition in pharmaceutical production emphasis to developing markets, and the rising Biosimilars industry both create major growth prospects for pharmaceutical excipients market players. Additionally, rise in the number of chronic illnesses, greater understanding of physical well-being, and increasing prevalence of lifestyle diseases such as diabetes and obesity-related disorders have all contributed to increased demand for drugs around the world. This has fueled demand for and manufacture of pharmaceuticals and excipients.

Rise in demand for Generic Drugs

Over the last decade, the generics sector has had a phenomenal streak, with businesses earning above-average shareholder returns. Generic products are generic versions of branded drugs that have the same dosage type, weight, route of delivery, and cost. According to statistics issued by the India Brand Equity Foundation (IBEF), India is one of the world's largest suppliers of generic drugs, accounting for 20% of global generic drug exports. In 2017, Indian pharmaceutical firms obtained clearance for 300 generic drugs in the United States. As a result, the global growth in generic drug sales has boosted demand for pharmaceutical excipients.

Regulatory hurdles restricting the development of novel pharmaceutical excipients

The lack of independent rules for excipient manufacturing and clearance is deterring R&D projects involving novel excipients. In the current regulatory environment, if a new drug application (NDA) fails, the excipient still fails, even if the failure is not attributed to the excipient. Furthermore, the evidence from the unsuccessful excipient's clinical trials were useless. Both the drug and the excipient maker suffer significant financial losses as a result of this. The cost and time required to produce novel excipients when adhering to regulatory requirements are both prohibitively expensive for manufacturers, reducing the likelihood of a novel excipient being accepted.

COVID-19 Impact Analysis

The growth of the global demand for Pharmaceutical Excipients is projected to increase throughout the emergence of the COVID-19 pandemic, as non-COVID-related healthcare facilities continue to run at a regular pace. The market for Pharmaceutical Excipients is expected to grow in the wake of the current COVID-19 pandemic. Market participants are required to concentrate on solving the supply chain issues raised by the COVID-19 pandemic and designing appropriate solutions to resolve them.

 Segment Analysis

Based on the Product, the Pharmaceutical Excipients market has been classified into Organic, Inorganic and Others.

Organic segment is projected to be the dominated segment in the market during the forecast period.

Organic dominated the global market in 2019, owing to the wide usage of organic in the majority of pharmaceutical formulations available in the pharmaceutical market. Whereas the organic is expected to present a considerable growth in the near future. As Natural excipients are primarily used in oral formulations as binders and fillers, which aids the segmental growth during the forecast period.

Pharmaceutical Excipients is segmented on the basis of Functionality, which includes Fillers, Diluents, Coatings, Disintegrants, Others.

Fillers is expected to dominate the Pharmaceutical Excipients market.

Fillers held the dominant position in the global market during the forecast period owing to increased use of fillers and diluents in the development and production of solid oral drugs and the advantages they offer to manufacturers and patients. Moreover, the Fillers is expected to project a considerable CAGR during the forecast period.

Source: DataM Intelligence Analysis (2019)

Pharmaceutical Excipients is segmented on the basis of Formulation, which includes Oral, Parenteral, Topical and Others.

Oral is expected to dominate the Pharmaceutical Excipients market.

Oral held the dominant position in the global market during the forecast period. As oral formulations are the most common route of drug delivery, which is supporting the segment growth during the forecast period. Moreover, the Topical is expected to project a considerable CAGR during the forecast period. Strong assimilation of topical excipients with liquid APIs and improved patient compliance due to sensorial effects are driving this segment's development.

Source: DataM Intelligence Analysis (2019)

 Geographical Analysis

Based on geography, the study analyzes the Pharmaceutical Excipients market in the global market, including North America, Europe, Asia-Pacific, South America, and the Middle East & Africa.

Europe is expected to dominate the global Pharmaceutical Excipients market

Europe held a dominant position in the global Pharmaceutical Excipients market in 2019. As Excipient consumption in the region is high due to the emergence of a variety of pharmaceutical behemoths with massive manufacturing capacities. The increased demand for novel excipients is also due to the increasing reliance on superior pharmaceutical drugs, generics, and biosimilars. Moreover, Europe is expected to represent significant growth in terms of value during the forecast period. Pharmaceutical Excipients market for Asia Pacific is expected to observe rapid growth over the forecast period, backed by the Large population base, especially in India and China. Moreover, the developing healthcare facilities, large number of generic manufacturer and rise in government initiatives and specialist communities is expected to augment the growth the Asia Pacific Pharmaceutical Excipients market.

 Competitive Landscape

The Pharmaceutical Excipients market is highly competitive, owing to the presence of big medical companies. The key Pharmaceutical Excipients players which are contributing to the growth of the global market include DuPont de Nemours Inc, Roquette Feres, Ashland Global Holdings Inc.., BASF SE., Evonik Industries AG., Associated British Foods plc, Archer Daniels Midland Company, Lubrizol Corporation, Croda International, Innophos Holdings, among others. The major players are adopting new Product launch and expansion strategies for global growth in the Pharmaceutical Excipients market.   

Plasdone™ S630 Ultra (Ashland Global Holdings Inc.):

PlasdoneTM S630 Ultra is a new and improved copovidone that is engineered to perform better in tablet formulations, hot melt extrusion (HME), and continuous manufacturing. As opposed to the original PlasdoneTM S630 copovodone, it has improved long-term stability for oxidatively susceptible APIs as well as the potential to lower production costs.

Product Portfolio: The Company's portfolio comprises Oral dosage and parenteral dosage forms among others.

Why Purchase the Report?

Visualize the Pharmaceutical Excipients market segmentation composition by product, functionality, formulation and region, highlighting the critical commercial assets and players.

Identify commercial opportunities in the Pharmaceutical Excipients market by analyzing trends and co-development deals.

Excel data sheet with thousands of data points of Pharmaceutical Excipients market - level 3 segmentation.

PDF report with the most relevant analysis cogently put together after exhaustive qualitative interviews and in-depth market study.

Product mapping in excel for the key Product of all major market players

The global Pharmaceutical Excipients market report would provide access to an approx. 56 market data table, 54 figures and 221 pages.

Target Audience

Service Providers/ Buyers

Industry Investors/Investment Bankers

Education & Research Institutes

Research Professionals

Emerging Companies

Manufacturers

Table of Contents

Table of Contents

Pharmaceutical Excipients Market Methodology and Scope

Research Methodology

Research Objective and Scope of the Report

Pharmaceutical Excipients Market - Market Definition and Overview

Pharmaceutical Excipients Market - Executive Summary

Market Snippet by Product

Market Snippet by Functionality

Market Snippet by Formulation

Market Snippet by Region

Pharmaceutical Excipients Market - Market Dynamics

Market Impacting Factors

Drivers

Rise in demand for Generic Drugs

Increasing Chronic condition

Restraints:

Regulatory hurdles restricting the development of novel pharmaceutical excipients

Impact Analysis

Pharmaceutical Excipients Market - Industry Analysis

Porter's Five Forces Analysis

Supply Chain Analysis

Value Chain Analysis

PEST Analysis

Pricing Analysis

Regulatory Analysis

Reimbursement Analysis

Unmet Needs

Patent Trends

Pharmaceutical Excipients Market - COVID-19 Analysis

Analysis of Covid-19 on the Market

Before COVID-19 Market Scenario

Present COVID-19 Market Scenario

After COVID-19 or Future Scenario

Pricing Dynamics Amid Covid-19

Demand-Supply Spectrum

Government Initiatives Related to the Market During Pandemic

Manufacturers Strategic Initiatives

Conclusion 

Pharmaceutical Excipients Market - By Product

Introduction

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product Segment

Market Attractiveness Index, By Product Segment

Organic*

Introduction

Market Size Analysis, and Y-o-Y Growth Analysis (%)

Inorganic

Other

Pharmaceutical Excipients Market - By Functionality

Introduction

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Functionality Segment

Market Attractiveness Index, By Functionality Segment

Fillers*

Introduction

Market Size Analysis, and Y-o-Y Growth Analysis (%)

Diluents

Coatings

Disintegrants

Others

Pharmaceutical Excipients Market - By Formulation

Introduction

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Formulation Segment

Market Attractiveness Index, By Formulation Segment

Oral*

Introduction

Market Size Analysis, and Y-o-Y Growth Analysis (%)

Parenteral

Topical

Others

Pharmaceutical Excipients Market - By Region

Introduction

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Region

Market Attractiveness Index, By Region

North America

Introduction

Key Region-Specific Dynamics

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Functionality

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Formulation

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

U.S.

Canada

Mexico

Europe

Introduction

Key Region-Specific Dynamics

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Functionality

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Formulation

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

Germany

U.K.

France

Italy

Spain

Rest of Europe

South America

Introduction

Key Region-Specific Dynamics

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Functionality

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Formulation  

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

Brazil

Argentina

Rest of South America

Asia Pacific

Introduction

Key Region-Specific Dynamics

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Functionality

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Formulation

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

China

India

Japan

Australia

Rest of Asia Pacific

Middle East and Africa

Introduction

Key Region-Specific Dynamics

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Product

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Functionality

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Formulation

Market Size Analysis, and Y-o-Y Growth Analysis (%), By Country

Pharmaceutical Excipients Market - Competitive Landscape

Competitive Scenario

Market Positioning/Share Analysis

Mergers and Acquisitions Analysis

Pharmaceutical Excipients Market- Company Profiles

DuPont de Nemours Inc*

Company Overview

Product Portfolio and Description

Key Highlights

Financial Overview

Roquette Feres.

Ashland Holdings Inc..

BASF SE.

Evonik Industries AG.

Associated British Foods plc

Archer Daniels Midland Company

Lubrizol Corporation.

Croda International

Innophos Holdings (LIST NOT EXHAUSTIVE)

Pharmaceutical Excipients Market - Premium Insights

Pharmaceutical Excipients Market - DataM Intelligence Analysis

Appendix

About Us and Services

Contact Us

Suggestions for Related Market Report:

Isotretinoin Drugs Market

Compounding Pharmacies market